Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $9.2700 (-2.93%) ($8.6600 - $10.7300) on Wed. Jul. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.47% (three month average) | RSI | 79 | Latest Price | $9.2700(-2.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 8.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 41.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) BNDX(49%) BND(33%) BWX(22%) CEMB(19%) VCSH(19%) | Factors Impacting CAPR price | CAPR will decline at least -4.235% in a week (0% probabilities). XLI(-23%) PAVE(-23%) IVE(-23%) XLB(-22%) VYM(-22%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.235% (StdDev 8.47%) | Hourly BBV | 0 () | Intraday Trend | 3.5% | | | |
|
5 Day Moving Average | $8.46(9.57%) | 10 Day Moving Average | $7.23(28.22%) | 20 Day Moving Average | $5.9(57.12%) | To recent high | -5.5% | To recent low | 85% | Market Cap | $183m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |